STOCK TITAN

Innovid Reports Q3 2024 Financial Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Innovid (NYSE:CTV) reported strong Q3 2024 financial results with revenue increasing 6% year-over-year to $38.3 million. The company achieved a significant turnaround with net income of $4.7 million, compared to a net loss of $2.7 million in Q3 2023. Adjusted EBITDA grew 29% to $8.4 million, marking the ninth consecutive quarter of margin expansion to 22%. CTV impression volume increased 13% year-over-year. The board approved a $20 million stock repurchase program. For Q4 2024, Innovid expects revenue between $37.5-39.5 million and updated its FY 2024 revenue guidance to $150.5-152.5 million.

Innovid (NYSE:CTV) ha riportato risultati finanziari solidi per il terzo trimestre del 2024, con un aumento del fatturato del 6% anno su anno, arrivando a 38,3 milioni di dollari. L'azienda ha registrato un notevole cambiamento con un utile netto di 4,7 milioni di dollari, rispetto a una perdita netta di 2,7 milioni di dollari nel terzo trimestre del 2023. EBITDA rettificato è cresciuto del 29% fino a 8,4 milioni di dollari, segnando il nono trimestre consecutivo di espansione del margine al 22%. Il volume delle impressioni CTV è aumentato del 13% rispetto all'anno precedente. Il consiglio ha approvato un programma di riacquisto di azioni da 20 milioni di dollari. Per il quarto trimestre del 2024, Innovid prevede un fatturato compreso tra 37,5 e 39,5 milioni di dollari e ha aggiornato le previsioni di fatturato per l'intero anno 2024 a 150,5-152,5 milioni di dollari.

Innovid (NYSE:CTV) presentó sólidos resultados financieros para el tercer trimestre de 2024, con un aumento en los ingresos del 6% interanual, alcanzando los 38,3 millones de dólares. La compañía logró un importante cambio con una ganancia neta de 4,7 millones de dólares, en comparación con una pérdida neta de 2,7 millones de dólares en el tercer trimestre de 2023. El EBITDA ajustado creció un 29% hasta 8,4 millones de dólares, marcando el noveno trimestre consecutivo de expansión del margen al 22%. El volumen de impresiones CTV aumentó un 13% interanual. La junta aprobó un programa de recompra de acciones por 20 millones de dólares. Para el cuarto trimestre de 2024, Innovid espera ingresos entre 37,5 y 39,5 millones de dólares y actualizó su guía de ingresos para el año fiscal 2024 a 150,5-152,5 millones de dólares.

Innovid (NYSE:CTV)는 2024년 3분기 재무 결과를 발표하며 전년 대비 6% 증가한 3,830만 달러의 수익을 기록했습니다. 회사는 3분기 270만 달러의 순손실에서 470만 달러의 순이익으로 큰 변화를 이뤘습니다. 조정된 EBITDA는 29% 증가하여 840만 달러에 도달하며, 9분기 연속으로 22%의 마진 확대를 기록했습니다. CTV 인상량은 전년 대비 13% 증가했습니다. 이사회는 2천만 달러 규모의 주식 매입 프로그램을 승인했습니다. 2024년 4분기에는 수익이 3,750만에서 3,950만 달러 사이일 것으로 예상하며, 2024 회계연도 수익 가이던스를 1억 5천 5백만에서 1억 5천 2백 5십만 달러로 업데이트했습니다.

Innovid (NYSE:CTV) a annoncé de solides résultats financiers pour le troisième trimestre de 2024, avec une augmentation de 6 % des revenus par rapport à l'année précédente, atteignant 38,3 millions de dollars. L'entreprise a connu un retournement significatif avec un bénéfice net de 4,7 millions de dollars, contre une perte nette de 2,7 millions de dollars au troisième trimestre 2023. L'EBITDA ajusté a augmenté de 29 % pour atteindre 8,4 millions de dollars, marquant le neuvième trimestre consécutif d'expansion de la marge à 22 %. Le volume des impressions CTV a augmenté de 13 % par rapport à l'année précédente. Le conseil d'administration a approuvé un programme de rachat d'actions de 20 millions de dollars. Pour le quatrième trimestre 2024, Innovid prévoit des revenus compris entre 37,5 et 39,5 millions de dollars et a mis à jour ses prévisions de revenus pour l'exercice 2024 à 150,5-152,5 millions de dollars.

Innovid (NYSE:CTV) hat für das dritte Quartal 2024 starke finanzielle Ergebnisse berichtet, mit einem Umsatzplus von 6% im Vergleich zum Vorjahr, was 38,3 Millionen Dollar entspricht. Das Unternehmen erreichte eine signifikante Wende mit einem Nettogewinn von 4,7 Millionen Dollar, verglichen mit einem Nettverlust von 2,7 Millionen Dollar im dritten Quartal 2023. Bereinigtes EBITDA wuchs um 29% auf 8,4 Millionen Dollar und markierte das neunte aufeinanderfolgende Quartal mit einer Margenausweitung auf 22%. Das CTV-Impressionsvolumen stieg um 13% im Vergleich zum Vorjahr. Der Vorstand genehmigte ein Aktienrückkaufprogramm in Höhe von 20 Millionen Dollar. Für das vierte Quartal 2024 erwartet Innovid einen Umsatz zwischen 37,5 und 39,5 Millionen Dollar und aktualisierte seine Umsatzprognose für das Geschäftsjahr 2024 auf 150,5-152,5 Millionen Dollar.

Positive
  • Revenue increased 6% YoY to $38.3 million
  • Net income improved by $7.4 million to $4.7 million
  • Adjusted EBITDA grew 29% YoY to $8.4 million
  • EBITDA margin expanded to 22%
  • CTV impression volume increased 13% YoY
  • $20 million stock repurchase program approved
  • Selected as Netflix's impression verification partner
Negative
  • Operating cash flow decreased by $0.5 million YoY to $6.0 million
  • Free Cash Flow declined by $0.3 million YoY to $3.7 million

Insights

Innovid's Q3 2024 results demonstrate strong financial health with notable improvements across key metrics. Revenue grew 6% to $38.3 million, while net income showed a remarkable turnaround from a $2.7 million loss to $4.7 million profit. The Adjusted EBITDA margin expansion to 22% marks nine consecutive quarters of improvement, indicating robust operational efficiency.

The newly announced $20 million stock buyback program signals management's confidence in the company's valuation and future prospects. With positive free cash flow of $3.7 million and strong partnerships with major streaming platforms like Netflix, the company is well-positioned in the growing CTV advertising market. The 13% year-over-year growth in CTV impression volume suggests continued market penetration.

The selection as one of two verification partners for Netflix's ad-supported platform represents a significant competitive advantage in the streaming advertising ecosystem. This partnership, combined with the LG Ad Solutions collaboration through the Harmony initiative, strengthens Innovid's market position in the rapidly evolving CTV landscape.

The company's Q4 guidance of $37.5-39.5 million in revenue and updated full-year projections of $150.5-152.5 million reflect cautious optimism. The consistent margin expansion and operational efficiency improvements position Innovid favorably against competitors in the ad-tech space, particularly as streaming platforms continue to gain scale and advertising budgets shift toward CTV.

  • Q3 2024 revenue increased 6% year-over-year to $38.3 million
  • Q3 2024 net income improved year-over-year to $4.7 million and Adjusted EBITDA* increased 29% year-over-year to $8.4 million
  • Adjusted EBITDA margin* increased to 22%, the ninth consecutive quarter of expansion
  • Company announces board approval to implement stock repurchase program

NEW YORK--(BUSINESS WIRE)-- Innovid Corp. (NYSE:CTV) (the "Company"), an independent software platform for the creation, delivery, measurement, and optimization of advertising across connected TV (CTV), linear TV, and digital, today announced financial results for the third quarter ended September 30, 2024.

“In the third quarter, we were encouraged by the solid growth in CTV as streaming platforms are gaining scale,” said Zvika Netter, Co-Founder and CEO. “We delivered the ninth consecutive quarter of improved Adjusted EBITDA margin* demonstrating our ability to expand profitability and our leverageable operating model. I am proud of our team for their hard work developing key partnerships with the world’s leading players such as Netflix, while also launching innovative new products and leading the charge in shaping the future of CTV advertising.”

Third Quarter 2024 Financial Summary

  • Revenue increased to $38.3 million, reflecting year-over-year growth of 6%, compared to $36.2 million for the same period in 2023.
  • Net income was $4.7 million, compared to a net loss of $2.7 million for the same period in 2023, a $7.4 million improvement year-over-year.
  • Adjusted EBITDA* grew to $8.4 million, an increase of 29% year-over-year, compared to $6.5 million for the same period in 2023, representing a 22% Adjusted EBITDA margin* up from 18% in the prior year period.
  • Cash provided by operating activities was $6.0 million, compared to $6.5 million for the same period in 2023, a $0.5 million decrease year-over-year.
  • Free Cash Flow* was $3.7 million, compared to Free Cash Flow* of $4.1 million for the same period in 2023, a $0.3 million decrease year-over-year.

Recent Business Highlights

  • CTV impression volume from ad serving and personalization increased 13% year-over-year.
  • Innovid was selected as one of two partners for impression verification within Netflix’s ad-supported platform, expanding its extensive coverage of the streaming universe.
  • LG Ad Solutions is the latest industry leader to join Innovid’s Harmony initiative.
  • Innovid won the 2024 AdExchanger Award for Most Innovative TV Advertising Technology for its Harmony Initiative.

Stock Repurchase Program

Innovid’s board of directors authorized the Company to implement a stock repurchase program of up to $20 million. Subject to the final terms of the program, it is expected that repurchases will be dependent upon market conditions, regulatory requirements and other considerations. “The executive team and board of directors are confident in Innovid’s strategy and growth potential,” said Mr. Netter. “We believe this stock repurchase program reinforces our commitment to our shareholders, and that the current stock price does not represent the value of our business. With our strong strategic and financial position, we trust we can create enhanced shareholder value in the coming quarters and years.”

Financial Outlook

Innovid is providing the following financial guidance for Q4 and updating its full year 2024 guidance:

  • Q4 2024 revenue in a range between $37.5 million and $39.5 million
  • Q4 2024 Adjusted EBITDA* in a range between $8.0 million and $10.0 million
  • FY 2024 revenue in a range between $150.5 million and $152.5 million
  • FY 2024 Adjusted EBITDA* in a range between $26.7 million and $28.7 million

*See non-GAAP financial measures and reconciliation of GAAP to non-GAAP tables.

Conference Call

The Company will host a conference call and webcast to discuss third quarter 2024 financial results today at 8:30 a.m. Eastern Time. Hosting the call will be Zvika Netter, Co-founder and Chief Executive Officer and Anthony Callini, Chief Financial Officer. The conference call will be available via webcast at investors.innovid.com. To participate via telephone, please dial (+1) 877-407-3211 (toll free) or (+1) 201-389-0862 (toll-free international).

Following the call, a replay of the webcast will be available for 90 days on the Innovid Investor Relations website.

Non-GAAP Financial Measures

This press release contains non-GAAP financial measures under the rules of the U.S. Securities and Exchange Commission, including Adjusted EBITDA, Adjusted EBITDA Margin, and Free Cash Flow. This non-GAAP information supplements and is not intended to represent a measure of performance in accordance with disclosures required by generally accepted accounting principles. Non-GAAP financial measures are used internally as measures of operational efficiency to understand and evaluate our core business operations, as well as comparisons to peers as similar measures are frequently used by securities analysts, investors, ratings agencies and other interested parties to evaluate businesses in our industry. Accordingly, Innovid believes it is useful for investors and others to review both GAAP and non-GAAP measures in order for (a) period-to-period comparisons of our core business, (b) comparisons to peers as similar measures are frequently used by securities analysts, investors, ratings agencies and other interested parties to evaluate businesses in our industry, and (c) providing an understanding and evaluation of our trends when comparing our operating results, on a consistent basis, by excluding items that we do not believe are indicative of our core operating performance. However, these non-GAAP financial measures should not take the place of GAAP financial measures in evaluating our business. The primary limitations associated with the use of non-GAAP financial measures are that these measures may not be directly comparable to the amounts reported by other companies and they do not include all items of income and expense that affect operations. Innovid management compensates for these limitations by considering the company’s financial results and outlook as determined in accordance with GAAP and by providing a detailed reconciliation of the non-GAAP financial measures to the most directly comparable GAAP measures in the tables attached to this press release. We are not able to provide a reconciliation of the projected Adjusted EBITDA to expected net (loss) income attributable to Innovid for the fourth quarter of 2024 or the full year of 2024, without unreasonable effort. This is due to the unknown effect, timing, and potential significance of the effects of taxes on income in multiple jurisdictions, finance (income)/expenses including valuations, among others. These items have in the past, and may in the future, significantly affect GAAP results in a particular period.

Forward-Looking Statements

This press release includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1996. The Company's actual results may differ from its expectations, estimates, and projections and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," "aim," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, the Company's expectations regarding its future financial results and expected growth. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results, including Innovid's ability to achieve and, if achieved, maintain profitability, decrease and/or changes in CTV audience viewership behavior, Innovid's failure to make the right investment decisions or to innovate and develop new solutions, inaccurate estimates or projections of future financial performance, Innovid's failure to manage growth effectively, the dependence of Innovid's revenues and business on the overall demand for advertising and a limited number of advertising agencies and advertisers, the actual or potential impacts of international conflicts and humanitarian crises on global markets, the rejection of digital advertising by consumers, future restrictions on Innovid's ability to collect, use and disclose data, market pressure resulting in a reduction of Innovid's revenues per impression, Innovid's failure to adequately scale its platform infrastructure, exposure to fines and liability if advertisers, publishers and data providers do not obtain necessary and requisite consents from consumers for Innovid to process their personal data, competition for employee talent, seasonal fluctuations in advertising activity, payment-related risks, interruptions or delays in services from third parties, errors, defects, or unintended performance problems in Innovid's platform, intense market competition, failure to comply with the terms of third party open source components, changes in tax laws or tax rulings, failure to maintain an effective system of internal controls over financial reporting, failure to comply with data privacy and data protection laws, infringement of third party intellectual property rights, difficulty in enforcing Innovid's own intellectual property rights, system failures, security breaches or cyberattacks, additional financing if required may not be available, the volatility of the price of Innovid's common stock and warrants, and other important factors discussed under the caption "Risk Factors" in Innovid's Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commissions (“SEC”) on February 29, 2024, as such factors may be updated from time to time in its other filings with the SEC, accessible on the SEC's website at www.sec.gov and the Investors Relations section of Innovid's website at investors.innovid.com. You should carefully consider the risks and uncertainties described in the documents filed by the Company from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Most of these factors are outside the Company's control and are difficult to predict. The Company cautions not to place undue reliance upon any forward-looking statements, including projections, which speak only as of the date made. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based.

About Innovid

Innovid (NYSE:CTV) is an independent software platform for the creation, delivery, measurement, and optimization of advertising across connected TV (CTV), linear, and digital. Through a global infrastructure that enables cross-platform ad serving, data-driven creative, and measurement, Innovid offers its clients always-on intelligence to optimize advertising investment across channels, platforms, screens, and devices. Innovid is an independent platform that leads the market in converged TV innovation, through proprietary technology and exclusive partnerships designed to reimagine TV advertising. Headquartered in New York City, Innovid serves a global client base through offices across the Americas, Europe, and Asia Pacific. To learn more, visit https://www.innovid.com/ or follow us on LinkedIn or X.

INNOVID, CORP. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited and in thousands)

 

 

 

 

 

 

 

September 30,

2024

 

December 31,

2023

Assets

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

34,564

 

 

$

49,585

 

Trade receivables, net

 

44,365

 

 

 

46,420

 

Prepaid expenses and other current assets

 

4,475

 

 

 

5,615

 

Total current assets

 

83,404

 

 

 

101,620

 

Long-term restricted deposits

 

423

 

 

 

412

 

Property and equipment, net

 

21,006

 

 

 

18,419

 

Goodwill

 

102,473

 

 

 

102,473

 

Intangible assets, net

 

21,305

 

 

 

24,318

 

Operating lease right of use asset

 

10,894

 

 

 

1,435

 

Other non-current assets

 

903

 

 

 

1,278

 

Total assets

$

240,408

 

 

$

249,955

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

Current liabilities:

 

 

 

Trade payables

$

3,793

 

 

$

2,810

 

Employee and payroll accruals

 

9,140

 

 

 

14,060

 

Lease liabilities—current portion

 

1,388

 

 

 

1,200

 

Accrued expenses and other current liabilities

 

9,397

 

 

 

7,426

 

Total current liabilities

 

23,718

 

 

 

25,496

 

Long-term debt

 

 

 

 

20,000

 

Lease liabilities—non-current portion

 

9,835

 

 

 

634

 

Other non-current liabilities

 

6,927

 

 

 

7,528

 

Warrants liability

 

411

 

 

 

307

 

Common stock

 

15

 

 

 

13

 

Additional paid-in capital

 

394,410

 

 

 

378,774

 

Accumulated deficit

 

(194,908

)

 

 

(182,797

)

Total stockholders’ equity

 

199,517

 

 

 

195,990

 

Total liabilities and stockholders’ equity

$

240,408

 

$

249,955

INNOVID, CORP. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited and in thousands, except share and per share data)

 

 

 

 

 

 

 

Three months ended

September 30,

 

Nine months ended

September 30,

 

 

 

2024

 

 

 

2023

 

 

 

2024

 

 

 

2023

 

Revenue

$

38,251

 

 

$

36,234

 

 

$

112,940

 

 

$

101,265

 

Cost of revenue (1)

 

8,917

 

 

 

8,428

 

 

 

26,746

 

 

 

25,284

 

Research and development (1)

 

7,021

 

 

 

6,486

 

 

 

20,646

 

 

 

20,479

 

Sales and marketing (1)

 

11,682

 

 

 

11,175

 

 

 

35,523

 

 

 

34,272

 

General and administrative (1)

 

9,238

 

 

 

9,753

 

 

 

29,070

 

 

 

28,327

 

Depreciation, amortization and long-lived assets impairment

 

2,836

 

 

 

4,714

 

 

 

8,291

 

 

 

8,808

 

Goodwill impairment

 

 

 

 

 

 

 

 

 

 

14,503

 

Operating loss

 

(1,443

)

 

 

(4,322

)

 

 

(7,336

)

 

 

(30,408

)

Finance income, net

 

(285

)

 

 

(290

)

 

 

(405

)

 

 

(3,013

)

Loss before taxes

 

(1,158

)

 

 

(4,032

)

 

 

(6,931

)

 

 

(27,395

)

Taxes on income

 

(5,823

)

 

 

(1,301

)

 

 

5,180

 

 

 

2,858

 

Net income (loss)

$

4,665

 

 

$

(2,731

)

 

$

(12,111

)

 

$

(30,253

)

 

 

 

 

 

 

 

 

Net income (loss) per share common share—basic and diluted

$

0.03

 

 

$

(0.02

)

 

$

(0.08

)

 

$

(0.22

)

Weighted-average number of shares used in computing net income (loss) per share:

 

 

 

 

 

 

 

Basic

 

146,822,073

 

 

 

139,607,389

 

 

 

144,664,912

 

 

 

137,826,099

 

Diluted

 

152,504,240

 

 

 

139,607,389

 

 

 

144,664,912

 

 

 

137,826,099

 

 

(1) Exclusive of depreciation, amortization, long-lived assets and goodwill impairment presented separately.

INNOVID, CORP. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(Unaudited and in thousands, except share and per share data)

 

 

Three months ended September 30, 2024

 

Common stock

 

Additional

paid-in capital

 

Accumulated

deficit

 

Total

stockholders’

equity

 

Shares

 

Amount

 

 

 

Balance as of June 30, 2024

145,803,657

 

$

14

 

$

388,467

 

$

(199,573

)

 

$

188,908

 

Stock-based compensation

 

 

 

 

 

5,710

 

 

 

 

5,710

 

Issuance of common stock:

 

 

 

 

 

 

 

 

 

—exercised options and RSUs vested

1,969,994

 

 

1

 

 

233

 

 

 

 

234

 

Net income

 

 

 

 

 

 

 

4,665

 

 

 

4,665

 

Balance as of September 30, 2024

147,773,651

 

$

15

 

$

394,410

 

$

(194,908

)

 

$

199,517

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended September 30, 2023

 

Common stock

 

Additional

paid-in capital

 

Accumulated

deficit

 

Total

stockholders’

equity

 

Shares

 

Amount

 

 

 

Balance as of June 30, 2023

138,737,104

 

$

13

 

$

367,970

 

$

(178,408

)

 

$

189,575

 

Stock-based compensation

 

 

 

 

 

5,919

 

 

 

 

5,919

 

Issuance of common stock:

 

 

 

 

 

 

 

 

 

—exercised options and RSUs vested

1,399,801

 

 

 

 

158

 

 

 

 

158

 

Net loss

 

 

 

 

 

 

 

(2,731

)

 

 

(2,731

)

Balance as of September 30, 2023

140,136,905

 

$

13

 

$

374,047

 

$

(181,139

)

 

$

192,921

 

 

 

 

 

 

 

 

 

 

 

 

Nine months ended September 30, 2024

 

Common stock

 

Additional

paid-in capital

 

Accumulated

deficit

 

Total

stockholders’

equity

 

Shares

 

Amount

 

 

 

Balance as of December 31, 2023

141,194,179

 

$

13

 

$

378,774

 

$

(182,797

)

 

$

195,990

 

Stock-based compensation

 

 

 

 

 

15,324

 

 

 

 

15,324

 

Issuance of common stock:

 

 

 

 

 

 

 

 

 

—exercised options and RSUs vested

6,579,472

 

 

2

 

 

312

 

 

 

 

314

 

Net loss

 

 

 

 

 

 

 

(12,111

)

 

 

(12,111

)

Balance as of September 30, 2024

147,773,651

 

 

15

 

$

394,410

 

$

(194,908

)

 

$

199,517

 

 

 

 

 

 

 

 

 

 

 

 

Nine months ended September 30, 2023

 

Common stock

 

Additional

paid-in capital

 

Accumulated

deficit

 

Total

stockholders

equity

 

Shares

 

Amount

 

 

 

Balance as of December 31, 2022

133,882,414

 

$

13

 

$

356,801

 

$

(150,886

)

 

$

205,928

 

Stock-based compensation

 

 

 

 

 

16,474

 

 

 

 

16,474

 

Issuance of common stock:

 

 

 

 

 

 

 

 

 

—exercised options and RSUs vested

6,254,491

 

 

 

 

772

 

 

 

 

772

 

Net loss

 

 

 

 

 

 

 

(30,253

)

 

 

(30,253

)

Balance as of September 30, 2023

140,136,905

 

$

13

 

$

374,047

 

$

(181,139

)

 

$

192,921

 

INNOVID, CORP. AND ITS SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

(Unaudited and in thousands)

 

 

 

 

 

Nine months ended

September 30,

 

 

 

2024

 

 

 

2023

 

Cash flows from operating activities:

 

 

 

Net loss

$

(12,111

)

 

$

(30,253

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

Depreciation, amortization and long-lived assets impairment

 

8,291

 

 

 

8,808

 

Loss on disposal of property and equipment

 

15

 

 

 

 

Goodwill impairment

 

 

 

 

14,503

 

Stock-based compensation

 

14,526

 

 

 

15,470

 

Change in fair value of warrants

 

104

 

 

 

(3,688

)

Loss on foreign exchange, net

 

321

 

 

 

 

Changes in operating assets and liabilities:

 

 

 

Trade receivables, net

 

2,055

 

 

 

94

 

Prepaid expenses and other assets

 

1,349

 

 

 

(1,167

)

Operating lease right of use assets

 

438

 

 

 

1,351

 

Trade payables

 

984

 

 

 

(36

)

Employee and payroll accruals

 

(4,920

)

 

 

1,770

 

Operating lease liabilities

 

(508

)

 

 

(1,683

)

Accrued expenses and other liabilities

 

1,371

 

 

 

2,268

 

Net cash provided by operating activities

 

11,915

 

 

 

7,437

 

Cash flows from investing activities:

 

 

 

Internal use software capitalization

 

(6,098

)

 

 

(7,795

)

Purchases of property and equipment

 

(983

)

 

 

(395

)

Withdrawal of short-term bank deposits

 

165

 

 

 

10,000

 

Increase in deposits

 

 

 

 

77

 

Net cash (used in) provided by investing activities

 

(6,916

)

 

 

1,887

 

Cash flows from financing activities:

 

 

 

Proceeds from loan

 

 

 

 

20,000

 

Payment on loan

 

(20,000

)

 

 

(20,000

)

Proceeds from exercise of options

 

312

 

 

 

772

 

Net cash (used in) provided by financing activities

 

(19,688

)

 

 

772

 

Effect of exchange rates on cash, cash equivalents and restricted cash

 

(321

)

 

 

 

(Decrease) increase in cash, cash equivalents, and restricted cash

 

(15,010

)

 

 

10,096

 

Cash, cash equivalents, and restricted cash at the beginning of the period

 

49,997

 

 

 

37,971

 

Cash, cash equivalents, and restricted cash at the end of the period

$

34,987

 

 

$

48,067

 

INNOVID, CORP. AND ITS SUBSIDIARIES

OTHER INFORMATION

(Unaudited and in thousands)

RECONCILIATION OF GAAP NET INCOME (LOSS) TO NON-GAAP ADJUSTED EBITDA AND ADJUSTED EBITDA MARGIN PERCENT

 

 

 

Three months ended

September 30,

 

Nine months ended

September 30,

 

 

2024

 

 

 

2023

 

 

 

2024

 

 

 

2023

 

Net income (loss)

$

4,665

 

 

$

(2,731

)

 

$

(12,111

)

 

$

(30,253

)

Net income (loss) margin percent

 

12

%

 

 

(8

)%

 

 

(11

)%

 

 

(30

)%

Depreciation, amortization and long-lived assets impairment

 

2,836

 

 

 

4,714

 

 

 

8,291

 

 

 

8,808

 

Goodwill impairment

 

 

 

 

 

 

 

 

 

 

14,503

 

Stock-based compensation

 

5,501

 

 

 

5,605

 

 

 

14,526

 

 

 

15,563

 

Finance income, net (a)

 

(285

)

 

 

(290

)

 

 

(405

)

 

 

(3,013

)

Retention bonus expenses (b)

 

(40

)

 

 

119

 

 

 

92

 

 

 

564

 

Legal claims and other legal matters

 

688

 

 

 

420

 

 

 

1,822

 

 

 

1,076

 

Severance cost

 

814

 

 

 

 

 

 

1,229

 

 

 

845

 

Other

 

 

 

 

(80

)

 

 

 

 

 

192

 

Taxes on income

 

(5,823

)

 

 

(1,301

)

 

 

5,180

 

 

 

2,858

 

Adjusted EBITDA

$

8,356

 

 

$

6,456

 

 

$

18,624

 

 

$

11,143

 

Adjusted EBITDA margin percent

 

21.8

%

 

 

17.8

%

 

 

16.5

%

 

 

11.0

%

(a)

 

Finance income, net consists mostly of remeasurement related to revaluation of our warrants, remeasurement of our foreign subsidiary’s monetary assets, liabilities and operating results, and our interest expense.

(b)

 

Retention bonus expenses consists of retention bonuses for certain TVS employees.

RECONCILIATION OF NET CASH PROVIDED BY OPERATING ACTIVITIES TO NON-GAAP FREE CASH FLOW

 

 

Three months ended

September 30,

 

Nine months ended

September 30,

 

 

2024

 

 

 

2023

 

 

 

2024

 

 

 

2023

 

Net cash provided by operating activities

$

6,029

 

 

$

6,489

 

 

$

11,915

 

 

$

7,437

 

Loss on foreign exchange, net

 

(70

)

 

 

 

 

 

(321

)

 

 

 

Capital expenditures

 

(2,214

)

 

 

(2,410

)

 

 

(7,081

)

 

 

(8,190

)

Free Cash Flow

$

3,745

 

 

$

4,079

 

 

$

4,513

 

 

$

(753

)

 

Investor Contact

Lauren Hartman

IR@innovid.com

Media Contacts

Megan Garnett Coyle

megan@innovid.com

Source: Innovid Corp.

FAQ

What was Innovid's (CTV) revenue growth in Q3 2024?

Innovid's revenue grew 6% year-over-year to $38.3 million in Q3 2024.

How much did Innovid's (CTV) net income improve in Q3 2024?

Innovid's net income improved by $7.4 million year-over-year, reaching $4.7 million compared to a net loss of $2.7 million in Q3 2023.

What is the size of Innovid's (CTV) stock repurchase program?

Innovid's board approved a stock repurchase program of up to $20 million.

What is Innovid's (CTV) revenue guidance for Q4 2024?

Innovid expects Q4 2024 revenue to be between $37.5 million and $39.5 million.

Innovid Corp.

NYSE:CTV

CTV Rankings

CTV Latest News

CTV Stock Data

278.91M
146.41M
13.41%
56.65%
0.98%
Advertising Agencies
Services-prepackaged Software
Link
United States of America
NEW YORK